BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06625320-completion@plaintrial.com
DTSTAMP:20261028T073356Z
DTSTART;VALUE=DATE:202712
SUMMARY:Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previousl
 y Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) — estimated
  completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06625320
URL:https://plaintrial.com/trial/NCT06625320
END:VEVENT
END:VCALENDAR